Sphera Funds Management as of Sept. 30, 2015
Portfolio Holdings for Sphera Funds Management
Sphera Funds Management holds 127 positions in its portfolio as reported in the September 2015 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Select Sector Spdr Tr Put Put Option | 8.4 | $66M | 10k | 6623.00 | |
Allergan SHS | 6.1 | $48M | 177k | 271.81 | |
Spdr S&p 500 Etf Tr Put Put Option | 6.0 | $47M | 2.5k | 19163.20 | |
Teva Pharmaceutical Inds Adr (TEVA) | 5.4 | $43M | 753k | 56.46 | |
Spdr Series Trust Put Put Option | 4.8 | $37M | 6.0k | 6225.00 | |
Ishares Tr Put Put Option | 3.9 | $30M | 1.0k | 30333.00 | |
Elbit Sys Ord (ESLT) | 3.7 | $29M | 101k | 289.90 | |
Biogen Idec (BIIB) | 3.2 | $25M | 85k | 291.81 | |
Pfizer (PFE) | 2.3 | $18M | 574k | 31.41 | |
Abbvie (ABBV) | 2.3 | $18M | 327k | 54.41 | |
Ormat Technologies (ORA) | 2.2 | $18M | 133k | 132.30 | |
Shire Sponsored Adr | 1.7 | $13M | 170k | 78.07 | |
BioMarin Pharmaceutical (BMRN) | 1.7 | $13M | 125k | 105.32 | |
Celgene Corporation | 1.7 | $13M | 120k | 108.17 | |
Mylan N V Call Call Option | 1.5 | $12M | 3.0k | 4026.00 | |
Gilead Sciences (GILD) | 1.5 | $12M | 120k | 98.19 | |
Incyte Corporation (INCY) | 1.4 | $11M | 100k | 110.33 | |
Clovis Oncology | 1.2 | $9.7M | 105k | 91.96 | |
Bristol Myers Squibb (BMY) | 1.1 | $8.9M | 150k | 59.20 | |
Cellcom Israel SHS (CELJF) | 1.1 | $8.8M | 358k | 24.60 | |
Perrigo Call Call Option (PRGO) | 1.1 | $8.6M | 547.00 | 15727.61 | |
Mylan N V Shs Euro | 1.0 | $8.1M | 200k | 40.26 | |
Acorda Therapeutics | 0.9 | $7.2M | 270k | 26.51 | |
Amgen (AMGN) | 0.9 | $6.9M | 50k | 138.33 | |
Horizon Pharma Call Call Option | 0.9 | $6.9M | 3.5k | 1982.00 | |
DepoMed | 0.9 | $6.8M | 360k | 18.85 | |
Select Sector Spdr Tr Sbi Cons Discr (XLY) | 0.8 | $6.6M | 89k | 74.26 | |
Vanda Pharmaceuticals (VNDA) | 0.7 | $5.8M | 513k | 11.28 | |
Check Point Software Tech Lt Ord (CHKP) | 0.7 | $5.7M | 72k | 79.33 | |
Alexion Pharmaceuticals | 0.7 | $5.5M | 35k | 156.40 | |
Tesaro | 0.6 | $4.7M | 118k | 40.10 | |
Amicus Therapeutics (FOLD) | 0.6 | $4.3M | 310k | 13.99 | |
Egalet | 0.5 | $4.3M | 325k | 13.18 | |
Ptc Therapeutics Call Call Option | 0.5 | $4.3M | 1.6k | 2670.00 | |
Intra Cellular Therapies (ITCI) | 0.5 | $4.2M | 105k | 40.04 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 0.5 | $4.2M | 40k | 104.15 | |
Alder Biopharmaceuticals | 0.5 | $4.1M | 125k | 32.76 | |
Portola Pharmaceuticals | 0.5 | $4.0M | 95k | 42.62 | |
Horizon Pharma SHS | 0.5 | $4.0M | 200k | 19.82 | |
Kempharm | 0.5 | $4.0M | 204k | 19.38 | |
Gw Pharmaceuticals Ads | 0.5 | $3.9M | 43k | 91.37 | |
United Therapeutics Corporation (UTHR) | 0.5 | $3.8M | 29k | 131.24 | |
Concert Pharmaceuticals I equity | 0.5 | $3.8M | 200k | 18.77 | |
Macrogenics (MGNX) | 0.5 | $3.6M | 170k | 21.42 | |
Starbucks Corporation (SBUX) | 0.5 | $3.6M | 63k | 56.84 | |
Raptor Pharmaceutical | 0.5 | $3.5M | 584k | 6.05 | |
Array Biopharma Call Call Option | 0.4 | $3.4M | 7.5k | 456.00 | |
AMAG Pharmaceuticals | 0.4 | $3.4M | 85k | 39.73 | |
Bellicum Pharma | 0.4 | $3.4M | 232k | 14.53 | |
Catalyst Pharmaceutical Partners (CPRX) | 0.4 | $3.3M | 1.1M | 3.00 | |
Alnylam Pharmaceuticals (ALNY) | 0.4 | $3.2M | 40k | 80.35 | |
Forward Pharma A/s Sponsored Adr | 0.4 | $3.2M | 135k | 23.56 | |
Kite Pharma | 0.4 | $3.2M | 57k | 55.68 | |
Cara Therapeutics (CARA) | 0.4 | $3.1M | 220k | 14.29 | |
Arrowhead Resh Corp Com New | 0.4 | $3.1M | 540k | 5.76 | |
Arbutus Biopharma (ABUS) | 0.4 | $3.1M | 505k | 6.09 | |
Insmed Com Par $.01 (INSM) | 0.4 | $3.1M | 165k | 18.57 | |
Cynapsus Therapeutics Com Par No Par | 0.4 | $3.1M | 189k | 16.19 | |
Retrophin | 0.4 | $3.0M | 150k | 20.26 | |
Therapeuticsmd | 0.4 | $3.0M | 513k | 5.86 | |
TJX Companies (TJX) | 0.4 | $3.0M | 42k | 71.43 | |
Ultragenyx Pharmaceutical (RARE) | 0.4 | $3.0M | 31k | 96.32 | |
Spark Therapeutics | 0.4 | $2.9M | 70k | 41.73 | |
Intercept Pharmaceuticals In | 0.4 | $2.9M | 18k | 165.89 | |
Valeant Pharmaceuticals Int | 0.4 | $2.8M | 16k | 178.35 | |
Exelixis (EXEL) | 0.4 | $2.8M | 500k | 5.61 | |
Foamix Pharmaceuticals SHS | 0.4 | $2.8M | 380k | 7.33 | |
Inotek Pharmaceuticals | 0.4 | $2.8M | 295k | 9.40 | |
Mirati Therapeutics | 0.4 | $2.8M | 80k | 34.42 | |
ISIS Pharmaceuticals | 0.4 | $2.7M | 68k | 40.43 | |
Palatin Technologies Com Par $ .01 | 0.3 | $2.7M | 3.4M | 0.81 | |
Five Prime Therapeutics | 0.3 | $2.7M | 175k | 15.39 | |
Nivalis Therapeutics | 0.3 | $2.6M | 202k | 12.97 | |
Catabasis Pharmaceuticals | 0.3 | $2.6M | 328k | 7.92 | |
Genocea Biosciences | 0.3 | $2.6M | 377k | 6.85 | |
Biotie Therapies Oyj Sponsored Adr | 0.3 | $2.6M | 197k | 13.09 | |
Cytokinetics Com New (CYTK) | 0.3 | $2.5M | 372k | 6.69 | |
Acceleron Pharma | 0.3 | $2.5M | 100k | 24.90 | |
Mondelez Intl Cl A (MDLZ) | 0.3 | $2.5M | 60k | 41.87 | |
Keryx Biopharmaceuticals | 0.3 | $2.5M | 700k | 3.52 | |
Dynavax Technologies Corp Com New (DVAX) | 0.3 | $2.5M | 100k | 24.54 | |
Abeona Therapeutics | 0.3 | $2.4M | 600k | 4.05 | |
Partner Communications Co Lt Adr | 0.3 | $2.4M | 618k | 3.91 | |
Uniqure Nv SHS (QURE) | 0.3 | $2.4M | 115k | 20.45 | |
Ellomay Capital SHS (ELLO) | 0.3 | $2.3M | 221k | 10.56 | |
Scynexis | 0.3 | $2.3M | 313k | 7.28 | |
Atyr Pharma Inc Common Stock Usd 0.001 | 0.3 | $2.1M | 209k | 10.26 | |
Summit Therapeutics Spons Ads | 0.3 | $2.1M | 205k | 10.41 | |
Cempra | 0.3 | $2.1M | 75k | 27.84 | |
Immune Design | 0.3 | $2.1M | 170k | 12.20 | |
Prothena Corp SHS (PRTA) | 0.3 | $2.0M | 45k | 45.33 | |
Aegerion Pharmaceuticals | 0.3 | $2.0M | 150k | 13.60 | |
Halozyme Therapeutics (HALO) | 0.3 | $2.0M | 150k | 13.43 | |
Wabtec Corporation (WAB) | 0.3 | $2.0M | 23k | 88.06 | |
Relypsa | 0.3 | $2.0M | 107k | 18.51 | |
Epizyme | 0.2 | $1.9M | 150k | 12.86 | |
Seattle Genetics | 0.2 | $1.9M | 50k | 38.56 | |
Trillium Therapeutics Com New | 0.2 | $1.9M | 147k | 13.03 | |
Novartis A G Sponsored Adr (NVS) | 0.2 | $1.8M | 20k | 91.90 | |
Sarepta Therapeutics (SRPT) | 0.2 | $1.8M | 55k | 32.11 | |
Neuroderm Ord Shs | 0.2 | $1.8M | 85k | 20.67 | |
Palo Alto Networks (PANW) | 0.2 | $1.7M | 10k | 171.97 | |
Nabriva Therapeutics Sponsored Adr | 0.2 | $1.7M | 175k | 9.50 | |
Pieris Pharmaceuticals | 0.2 | $1.6M | 900k | 1.83 | |
Zogenix Com New | 0.2 | $1.6M | 120k | 13.50 | |
Array BioPharma | 0.2 | $1.6M | 350k | 4.56 | |
Ocera Therapeutics | 0.2 | $1.6M | 500k | 3.16 | |
Aldeyra Therapeutics (ALDX) | 0.2 | $1.5M | 265k | 5.83 | |
Carbylan Therapeutics Inc Common Stock Usd 0.001 | 0.2 | $1.4M | 400k | 3.57 | |
Marinus Pharmaceuticals | 0.2 | $1.4M | 162k | 8.34 | |
Tobira Therapeutics Inc Common Stock Usd 0.0001 | 0.2 | $1.3M | 138k | 9.66 | |
Zafgen | 0.2 | $1.3M | 40k | 31.95 | |
Colucid Pharmaceuticals | 0.2 | $1.2M | 317k | 3.87 | |
Heron Therapeutics (HRTX) | 0.2 | $1.2M | 50k | 24.40 | |
Orbotech Ord | 0.2 | $1.2M | 79k | 15.46 | |
Anacor Pharmaceuticals In | 0.2 | $1.2M | 10k | 117.70 | |
Novavax | 0.1 | $1.1M | 150k | 7.07 | |
Axalta Coating Sys (AXTA) | 0.1 | $1.0M | 41k | 25.33 | |
Wix SHS (WIX) | 0.1 | $1.0M | 58k | 17.42 | |
Genvec Com New | 0.1 | $832k | 360k | 2.31 | |
Charter Communications Inc D Cl A New | 0.1 | $708k | 4.0k | 175.86 | |
Delphi Automotive SHS | 0.1 | $696k | 9.2k | 76.07 | |
A. O. Smith Corporation (AOS) | 0.1 | $681k | 10k | 65.22 | |
Sage Therapeutics (SAGE) | 0.0 | $339k | 8.0k | 42.38 | |
Nice Sys Sponsored Adr (NICE) | 0.0 | $255k | 4.5k | 56.35 | |
Ptc Therapeutics I (PTCT) | 0.0 | $107k | 4.0k | 26.75 | |
Aimmune Therapeutics | 0.0 | $5.0k | 200.00 | 25.00 |